Access to this symposium requires
KEY ZONE
access (paid registration) to HDCN. For information about subscribing to HDCN, please go to
this link
.
ASDIN members have free access to this material. See the members only section of the
ASDIN website
.
PART 16
NON-DIALYSIS PROCEDURES and TECHNIQUES
LINK
Port Placement, removal and Management
Thomas Vesely, MD
Click here to go
to PART XVI
IVC Filter: Indications, Placement, Complications
Dheeraj Rajan, MD
Varicose Vein Therapy: An introduction to Surgical and Endovascular Treatment
Abigail Falk, MD
PART 15
REALITY CHECK: BUSINESS AND POLICY OF AV ACCESS
LINK
Drug Shortages
Aris Q. Urbanes, MD
Click here to go
to PART XV
True Lies: Ethical Behavior when patient has not received optimal care
Timothy A. Pflederer, MD
Intersection of Regulatory Bodies
Robert Blaser, MD
The Economics of Fistula First
Timothy A. Pflederer, MD
Interventional Nephrology and the Accountable Care Organization Model
Robert Blaser, MD
Closing Remarks and Adjournment
Haimanot Wasse, MD
PART 14
ADVANCES IN AV ACCESS
LINK
Arterial Elasticity and AVF maturation
William D. Paulson, MD
Click here to go
to PART XIV
Pre-existing Vascular Calcification and AVF Maturation
Timmy Lee, MD
Tissue-engineered vascular grafts
Jeffrey H. Lawson, MD
Optiflow Vascular Anastomosis Device
Eric K. Peden, MD
Extending Access Site Patency with Novel Devices
Jeffrey H. Lawson, MDn, MD
PART 13
ACCESS COMPLICATIONS: Point/Counterpoint
LINK
First line Treatment of Peripheral Vein Stenosis Should be With a Covered Stent
Ziv J. Haskal MD
Click here to go
to PART XIII
Don’t Stent: Surgical Management is Best
David Fox, MD
Rebuttal
Drs. Haskel, and Fox
Symptomatic Central Venous Obstruction is Best Treated with PTA and Stenting
Dheeraj K. Rajan MD
Surgical Treatment is The Optimal for Symptomatic Central Venous Obstruction
Karl A. Illig, MD
Rebuttal
Drs. Rajan, and Illig
PART 12
ACCESS COMPLICATIONS: High Flow AVFs
LINK
Recognition and Diagnosis of high-flow fistula
Dirk Hentschel, MD
Click here to go
to PART XII
Surgical treatment options for the "Mega-AVF"
Karl A. Illig, MD
Endovascular treatment options for the "Mega-AVF"
Tony Samaha, MD
Q and A - Discussion
Drs.
Hentschel,
Illig, and Samaha
PART 11
New Initiatives for ASDIN
LINK
Affiliation and Collaboration
Aris Urbanes, MD
Click here to go
to PART XI
Vascular access procedures and infection: time for evidence-based policy
Charmaine Lok, MD
Developing Internventional Nephrology in Australia/New Zealand
Stephen May, MD
PART 10
ASDIN AWARDS Presentation
LINK
Gerald Beathard Award - awarded to Charmaine E. Lok, MD
Alex S. Yevzlin, MD
Click here to go
to PART X
ASDIN Distinguish Service Award - awarded to Timothy A. Pflederer, MD
Gerald Beathard, MD
PART 9
Vascular Access Placement in the Medically Challenged Patient
LINK
Access Placement in the Patient With Central Venous Occlusion
Surendra Shenoy, MD
Click here to go
to PART IX
Ipsilateral Access After Axillary Lymph Node Dissection
David Fox, MD
Ipsilateral Access in the Atrophied Limb
Surendra Shenoy, MD
PART 8
Point/Counterpoint
LINK
Surgical Management is Ideal for Aneurysm/Pseudoaneurysm
John R. Ross, MD
Click here to go
to PART VIII
Stent Graft Should Be Attempted Before Surgical Referral for Aneurysm/Pseudoaneurysm
Abigail Falk, MD
PART 7
Journal Club: Hot Topics in the Literature
LINK
Stent Graft and 180 day patency result
Gerald A. Beathard, MD
Click here to go
to PART VII
Fish Oil to Increase AVG patency
Charmaine E. Lok, MD
Anti-microbial locks increase bacterema
Vandana Dua Niyyar, MD
PART 6
NUTS AND BOLTS OF ENDOVASCULAR INTERVENTION : Morbidity and Mortality
LINK
PTA is the Best Therapy for Cephalic Arch and Central Vein Stenosis
Theodore F. Saad, MD
Click here to go
to PART VI
Stent Graft Placement is Best for Cephalic Arch and Central Veni Stenosis
Thomas Vesely, MD
Patients should return for scheduled follow up after access intervention
Dheeraj Rajan, MD
Patients Should NOT Have Scheduled Follow up after access intervention
Abigail Falk, MD
PART 5
Point/Counterpoint
LINK
PTA is the Best Therapy for Cephalic Arch and Central Vein Stenosis
Ziv J. Haskal, MD
Click here to go
to PART V
Stent Graft Placement is Best for Cephalic Arch and Central Veni Stenosis
Dheeraj K. Rajan, MD
Patients should return for scheduled follow up after access intervention
Gregg A Miller, MD
Patients Should NOT Have Scheduled Follow up after access intervention
Jack Work, MD
Stenting Over Transvenous CIED Leads Is Acceptable for Recurrent Patients
Theodore F. Saad, MD
Stenting Over Transvenous CIED Leads Should Never be Considered...EVER
Arif Asif, MD
PART 4
Access Selection and Preservation
LINK
Access Selection in Failed Transplant Recipients
Prabir Roy-Chaudhury
Click here to go
to PART IV
Ongoing Controversies in Dialysis Vascular Access Surveillance
William D. Paulson, MD
Fundamentals of Arterial and Venous Angioplasty
Thomas M. Vesely, MD
Vascular Access in the CKD Patient (and the General Public)
Jack Le Donne MD
Alternative Vascular Access for patient who has "used up everything"
Surendra Shenoy MD
PART 3
PD and Catheter Placement
LINK
Increasing Access to PD for Incident Dialysis Patients
Timothy A. Pflederer, MD
Click here to go
to PART III
Percutaneous Fluoroscopic Peritoneal Dialysis Catheter Insertion
Rajeev Narayan, MD
The Role of Surgical PD Catheter Placement in the Interventional Era
David Fox, MD
Urgent Start PD: The Caveats and Optimal Placement Technique
Kenneth Abreo, MD
PART 2
Gerald Beathard State of the Art Lecture
LINK
Can Interventional Nephrology Programs Help Popularize Home Dialysis Therapies?
Stephen Ash, MD
Click here to go
to PART II
PART 1
ASDIN Scientific Meeting: Welcome and President’s Address
LINK
Welcome and President’s Address
Aris Q. Urbanes, MD
Click here to go
to PART I
HDCN home
/
about our site
/
subscribe to key zone
/
register for free zone
update email address
/
subscription status
/
forget your password?